Literature DB >> 22825117

In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii.

Louis de Léséleuc1, Greg Harris, Rhonda KuoLee, Wangxue Chen.   

Abstract

We investigated the ability of compounds interfering with iron metabolism to inhibit the growth of Acinetobacter baumannii. Iron restriction with transferrin or 2,2-bipyridyl significantly inhibited A. baumannii growth in vitro. Gallium nitrate alone was moderately effective at reducing A. baumannii growth but became bacteriostatic in the presence of serum or transferrin. More importantly, gallium nitrate treatment reduced lung bacterial burdens in mice. The use of gallium-based therapies shows promise for the control of multidrug-resistant A. baumannii.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825117      PMCID: PMC3457350          DOI: 10.1128/AAC.00778-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  The acute-phase response and serum amyloid A inhibit the inflammatory response to Acinetobacter baumannii Pneumonia.

Authors:  Rosemarijn Renckens; Joris J T H Roelofs; Sylvia Knapp; Alex F de Vos; Sandrine Florquin; Tom van der Poll
Journal:  J Infect Dis       Date:  2005-12-07       Impact factor: 5.226

Review 2.  Iron metabolism and the innate immune response to infection.

Authors:  Erin E Johnson; Marianne Wessling-Resnick
Journal:  Microbes Infect       Date:  2011-10-20       Impact factor: 2.700

3.  Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem.

Authors:  M L Joly-Guillou; M Wolff; J J Pocidalo; F Walker; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

4.  Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Authors:  J R Boelaert; M de Locht; J Van Cutsem; V Kerrels; B Cantinieaux; A Verdonck; H W Van Landuyt; Y J Schneider
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

5.  Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice.

Authors:  Katrina DeLeon; Fredrik Balldin; Chase Watters; Abdul Hamood; John Griswold; Sunil Sreedharan; Kendra P Rumbaugh
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

Review 6.  Medical applications and toxicities of gallium compounds.

Authors:  Christopher R Chitambar
Journal:  Int J Environ Res Public Health       Date:  2010-05-10       Impact factor: 3.390

7.  Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium avium.

Authors:  Sofia Sousa Fernandes; Ana Nunes; Ana Rita Gomes; Baltazar de Castro; Robert C Hider; Maria Rangel; Rui Appelberg; Maria Salomé Gomes
Journal:  Microbes Infect       Date:  2010-01-25       Impact factor: 2.700

8.  The iron chelator deferasirox protects mice from mucormycosis through iron starvation.

Authors:  Ashraf S Ibrahim; Teclegiorgis Gebermariam; Yue Fu; Lin Lin; Mohamed I Husseiny; Samuel W French; Julie Schwartz; Christopher D Skory; John E Edwards; Brad J Spellberg
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

9.  Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice.

Authors:  Henk van Faassen; Rhonda KuoLee; Greg Harris; Xigeng Zhao; J Wayne Conlan; Wangxue Chen
Journal:  Infect Immun       Date:  2007-10-01       Impact factor: 3.441

10.  Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability.

Authors:  L R Bernstein; T Tanner; C Godfrey; B Noll
Journal:  Met Based Drugs       Date:  2000
View more
  27 in total

Review 1.  Connecting iron acquisition and biofilm formation in the ESKAPE pathogens as a strategy for combatting antibiotic resistance.

Authors:  Savannah J Post; Justin A Shapiro; William M Wuest
Journal:  Medchemcomm       Date:  2019-03-21       Impact factor: 3.597

2.  The dual personality of iron chelators: growth inhibitors or promoters?

Authors:  Paolo Visca; Carlo Bonchi; Fabrizia Minandri; Emanuela Frangipani; Francesco Imperi
Journal:  Antimicrob Agents Chemother       Date:  2013-05       Impact factor: 5.191

3.  Reply to "The Dual personality of iron chelators: growth inhibitors or promoters?".

Authors:  Daniel V Zurawski; Anna C Jacobs; Mitchell G Thompson; Thomas J Palys
Journal:  Antimicrob Agents Chemother       Date:  2013-05       Impact factor: 5.191

4.  New insights into the bacterial RNA polymerase inhibitor CBR703 as a starting point for optimization as an anti-infective agent.

Authors:  Weixing Zhu; Jörg Haupenthal; Matthias Groh; Michelle Fountain; Rolf W Hartmann
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

5.  Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice.

Authors:  Maria Del Carmen Parquet; Kimberley A Savage; David S Allan; M Trisha C Ang; Wangxue Chen; Susan M Logan; Bruce E Holbein
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

6.  Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum.

Authors:  Carlo Bonchi; Emanuela Frangipani; Francesco Imperi; Paolo Visca
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

7.  Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection.

Authors:  Greg Harris; Bruce E Holbein; Hongyan Zhou; H Howard Xu; Wangxue Chen
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

8.  In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii.

Authors:  Luísa C S Antunes; Francesco Imperi; Fabrizia Minandri; Paolo Visca
Journal:  Antimicrob Agents Chemother       Date:  2012-09-10       Impact factor: 5.191

9.  Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes.

Authors:  Brock A Arivett; Steven E Fiester; Emily J Ohneck; William F Penwell; Cynthia M Kaufman; Ryan F Relich; Luis A Actis
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

10.  Gallium nitrate is efficacious in murine models of tuberculosis and inhibits key bacterial Fe-dependent enzymes.

Authors:  Oyebode Olakanmi; Banurekha Kesavalu; Rajamouli Pasula; Maher Y Abdalla; Larry S Schlesinger; Bradley E Britigan
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.